{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T03:12:50Z","timestamp":1783912370050,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Program of Excellent Talents in Medical Science of Jiangsu Province","award":["JCRCA2016006"],"award-info":[{"award-number":["JCRCA2016006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Essential thrombocythemia (ET) is a myeloproliferative neoplasm characterized by elevated and dysfunctional platelets. ET can result in systemic thrombotic and hemorrhagic complications, and it\u2019s a rare cause of stroke. The coexistence of multiple vascular lesions has seldom been reported in patients with essential thrombocythemia.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A young woman presented with isolated and persistent vertigo and vomiting. The CT scan indicated a hyperdense lesion in the right cerebellar hemisphere. No signs of cerebral artery malformation were observed in the CT angiography (CTA). Besides, the blood tests indicated an increase in platelet and white blood cell counts. The patient then suddenly developed a transient unconsciousness with left horizontal nystagmus when staring to the right. The subsequent cranial magnetic resonance imaging (MRI) scans indicated a diffuse and acute infarction of the pons and hemorrhage in the bilateral cerebellums. Further digital subtraction angiography (DSA) revealed a progressive and critical intracranial vertebral arterial occlusion. The patient\u2019s clinical condition stabilized after cytoreductive therapy with interferon-\u03b1 (IFN-\u03b1), even though endovascular and antiplatelet treatments were restricted because of the simultaneous presence of intracerebral hemorrhage (ICH) and ischemic stroke. A <jats:italic>JAK2 V617F<\/jats:italic> mutation was later detected through genetic testing, further confirming the diagnosis of ET. The patient was treated with a continuous regimen of IFN-\u03b1, and an antiplatelet treatment (aspirin) was added after ICH. The 1-year follow-up indicated normal platelet levels and no additional stroke event.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This case demonstrates that ET can be a rare cause of the cerebrovascular disease (CVD), even though the coexistence of ischemic and hemorrhagic complications. Underlying hematological system diseases should be taken into account when abnormal hemogram and CVD are concurrent in a patient. An early multidisciplinary diagnosis and intervention could significantly improve patient\u2019s prognosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-020-01986-9","type":"journal-article","created":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T04:40:38Z","timestamp":1604724038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Complex intracranial vascular complications caused by essential thrombocythemia: a critical case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Jian","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiyu","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5480-0888","authenticated-orcid":false,"given":"Zhijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,7]]},"reference":[{"issue":"22","key":"1986_CR1","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1056\/NEJMcp1816082","volume":"381","author":"A Tefferi","year":"2019","unstructured":"Tefferi A, Pardanani A. Essential Thrombocythemia. N Engl J Med. 2019;381(22):2135\u201344.","journal-title":"N Engl J Med"},{"issue":"3","key":"1986_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/hon.816","volume":"25","author":"F Radaelli","year":"2007","unstructured":"Radaelli F, Colombi M, Calori R, Zilioli VR, Bramanti S, Iurlo A, et al. Analysis of risk factors predicting thrombotic and\/or haemorrhagic complications in 306 patients with essential thrombocythemia. Hematol Oncol. 2007;25(3):115\u201320.","journal-title":"Hematol Oncol"},{"issue":"10","key":"1986_CR3","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1007\/s10072-018-3462-7","volume":"39","author":"J Yuan","year":"2018","unstructured":"Yuan J, Wu Y, Hao J, Hu W. The comorbidity of acute ischemic stroke and splenic infarction resulting from essential thrombocythemia. Neurol Sci. 2018;39(10):1787\u201390.","journal-title":"Neurol Sci"},{"issue":"6","key":"1986_CR4","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ejim.2004.04.014","volume":"15","author":"KN Vemmos","year":"2004","unstructured":"Vemmos KN, Spengos K, Tsivgoulis G, Manios E. Progressive stroke due to essential thrombocythemia. Eur J Intern Med. 2004;15(6):390\u20132.","journal-title":"Eur J Intern Med"},{"issue":"6","key":"1986_CR5","doi-asserted-by":"publisher","first-page":"748","DOI":"10.4103\/0366-6999.226903","volume":"131","author":"WB Chen","year":"2018","unstructured":"Chen WB, Wang XL. Cerebral venous sinus thrombosis as the first manifestation of JAK2(V617F)-positive essential Thrombocythemia. Chin Med J. 2018;131(6):748\u201350.","journal-title":"Chin Med J"},{"issue":"5","key":"1986_CR6","doi-asserted-by":"publisher","first-page":"e373","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.12.013","volume":"23","author":"R Adam","year":"2014","unstructured":"Adam R, Priglinger M, Harrington T, Gottlieb D, Krause M. An unusual cause of cerebellar hemorrhage in a young patient: essential thrombocythemia. J Stroke Cerebrovasc Dis. 2014;23(5):e373\u20134.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"8","key":"1986_CR7","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1007\/s00415-019-09347-4","volume":"266","author":"M Sugiyama","year":"2019","unstructured":"Sugiyama M, Ueno Y, Kamo H, Edahiro Y, Miyamoto N, Yamashiro K, et al. Specific mechanisms of subarachnoid hemorrhage accompanied by ischemic stroke in essential thrombocythemia: two case reports and a literature review. J Neurol. 2019;266(8):1869\u201378.","journal-title":"J Neurol"},{"issue":"20","key":"1986_CR8","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391\u2013405.","journal-title":"Blood."},{"issue":"8","key":"1986_CR9","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.3324\/haematol.2018.200832","volume":"104","author":"JC Ianotto","year":"2019","unstructured":"Ianotto JC, Curto-Garcia N, Lauermanova M, Radia D, Kiladjian JJ, Harrison CN. Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: a systematic review. Haematologica. 2019;104(8):1580\u20138.","journal-title":"Haematologica."},{"issue":"12","key":"1986_CR10","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1080\/10428194.2017.1312371","volume":"58","author":"S Chuzi","year":"2017","unstructured":"Chuzi S, Stein BL. Essential thrombocythemia: a review of the clinical features, diagnostic challenges, and treatment modalities in the era of molecular discovery. Leuk Lymphoma. 2017;58(12):2786\u201398.","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"1986_CR11","first-page":"773","volume":"15","author":"A Kleman","year":"2017","unstructured":"Kleman A, Singavi AK, Michaelis LC. Current challenges in the management of essential thrombocythemia. Clin Adv Hematol Oncol. 2017;15(10):773\u201383.","journal-title":"Clin Adv Hematol Oncol"},{"issue":"1","key":"1986_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/ajh.25303","volume":"94","author":"A Tefferi","year":"2019","unstructured":"Tefferi A, Barbui T. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management. Am J Hematol. 2019;94(1):133\u201343.","journal-title":"Am J Hematol"},{"issue":"2","key":"1986_CR13","first-page":"110","volume":"27","author":"R Malecki","year":"2016","unstructured":"Malecki R, Gacka M, Kuliszkiewicz-Janus M, Jakobsche-Policht U, Kwiatkowski J, Adamiec R, et al. Altered plasma fibrin clot properties in essential thrombocythemia. Platelets. 2016;27(2):110\u20136.","journal-title":"Platelets."},{"issue":"2","key":"1986_CR14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/MAJ.0000000000000497","volume":"350","author":"L Chen","year":"2015","unstructured":"Chen L, Li J, Tai H. Essential thrombocythemia-related stroke and improvement with tissue plasminogen activator. Am J Med Sci. 2015;350(2):152.","journal-title":"Am J Med Sci"},{"issue":"1","key":"1986_CR15","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.07.003","volume":"23","author":"M Naganuma","year":"2014","unstructured":"Naganuma M, Isoda K, Nishi S, Ito K, Hirano T. Repeated episodes of ischemic stroke over a short period in a patient with essential thrombocythemia on anticoagulant therapy. J Stroke Cerebrovasc Dis. 2014;23(1):166\u20138.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"7","key":"1986_CR16","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/j.1468-1331.2010.03183.x","volume":"18","author":"S Richard","year":"2011","unstructured":"Richard S, Perrin J, Baillot PA, Lacour JC, Ducrocq X. Ischaemic stroke and essential thrombocythemia: a series of 14 cases. Eur J Neurol. 2011;18(7):995\u20138.","journal-title":"Eur J Neurol"},{"key":"1986_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1750-1172-2-3","volume":"2","author":"JB Briere","year":"2007","unstructured":"Briere JB. Essential thrombocythemia. Orphanet J Rare Dis. 2007;2:3.","journal-title":"Orphanet J Rare Dis"},{"key":"1986_CR18","doi-asserted-by":"crossref","unstructured":"Awada H, Voso MT, Guglielmelli P, Gurnari C. Essential thrombocythemia and acquired von willebrand syndrome: the shadowlands between thrombosis and bleeding. Cancers (Basel). 2020;12(7):1746.","DOI":"10.3390\/cancers12071746"},{"issue":"4","key":"1986_CR19","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1161\/STROKEAHA.107.500868","volume":"39","author":"A Rosell","year":"2008","unstructured":"Rosell A, Cuadrado E, Ortega-Aznar A, Hernandez-Guillamon M, Lo EH, Montaner J. MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. Stroke. 2008;39(4):1121\u20136.","journal-title":"Stroke."},{"issue":"3","key":"1986_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/NEN.0b013e31820d94a5","volume":"70","author":"I Moxon-Emre","year":"2011","unstructured":"Moxon-Emre I, Schlichter LC. Neutrophil depletion reduces blood-brain barrier breakdown, axon injury, and inflammation after intracerebral hemorrhage. J Neuropathol Exp Neurol. 2011;70(3):218\u201335.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"11","key":"1986_CR21","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1182\/bloodadvances.2019000211","volume":"3","author":"A Carobbio","year":"2019","unstructured":"Carobbio A, Ferrari A, Masciulli A, Ghirardi A, Barosi G, Barbui T. Leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera: a systematic review and meta-analysis. Blood Adv. 2019;3(11):1729\u201337.","journal-title":"Blood Adv"},{"key":"1986_CR22","doi-asserted-by":"publisher","first-page":"bcr08","DOI":"10.1136\/bcr.08.2008.0720","volume":"2009","author":"J Kondlapudi","year":"2009","unstructured":"Kondlapudi J, O'Connor RJ, Mawer S. Cerebral haemorrhage as the presenting feature of myeloproliferative disorder. BMJ Case Rep. 2009;2009:bcr08.","journal-title":"BMJ Case Rep"},{"issue":"3","key":"1986_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3340\/jkns.2014.56.3.257","volume":"56","author":"JW Baek","year":"2014","unstructured":"Baek JW, Kim YD. Cerebral dissecting aneurysms in patients with essential thrombocythemia. J Korean Neurosurg Soc. 2014;56(3):257\u201360.","journal-title":"J Korean Neurosurg Soc"},{"issue":"6","key":"1986_CR24","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/ajh.22024","volume":"86","author":"V De Stefano","year":"2011","unstructured":"De Stefano V, Rossi E, Za T, Ciminello A, Betti S, Luzzi C, et al. JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis. Am J Hematol. 2011;86(6):526\u20138.","journal-title":"Am J Hematol"},{"issue":"10","key":"1986_CR25","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1002\/(SICI)1097-0142(19960515)77:10<2157::AID-CNCR29>3.0.CO;2-T","volume":"77","author":"A Mele","year":"1996","unstructured":"Mele A, Visani G, Pulsoni A, Monarca B, Castelli G, Stazi MA, et al. Risk factors for essential thrombocythemia: a case-control study. Italian Leukemia Study Group. Cancer. 1996;77(10):2157\u201361.","journal-title":"Cancer"},{"issue":"Suppl (3)","key":"1986_CR26","first-page":"9","volume":"25","author":"R Falcetta","year":"2003","unstructured":"Falcetta R, Sacerdote C, Bazzan M, Pollio B, Ciocca Vasino MA, Ciccone G, et al. Occupational and environmental risk factors for essential thrombocythemia: a case-control study. G Ital Med Lav Ergon. 2003;25(Suppl (3)):9\u201312.","journal-title":"G Ital Med Lav Ergon"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01986-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-020-01986-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01986-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T20:13:17Z","timestamp":1604866397000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-020-01986-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1986"],"URL":"https:\/\/doi.org\/10.1186\/s12883-020-01986-9","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,7]]},"assertion":[{"value":"22 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Ethical Committee of Nanjing ZhongDa Hospital, Southeast University, and the patient signed written informed consent before obtain the data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any associated images. A copy of the written consent is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"407"}}